Kiniksa Pharmaceuticals International, plc (KNSA) at a glance

Kiniksa Pharmaceuticals International, plc (KNSA) is a mid-cap Healthcare company. It trades at $76.27, with a P/E of 57, a 9.7% profit margin and revenue growth of 55.5%. It does not pay a dividend. Vestovix scores it 63/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Value (20/100). It is a relatively defensive holding with below-market volatility.

Price

$76.27

Market cap

$3.99B

P/E ratio

57.0

Dividend yield

None

Beta

0.12

52-week range

$33.25 to $82.94